A revolution related to GLP-1 is having implications for health, inequality, and the food system. The use of weight-loss injections, such as Ozempic, is raising ethical concerns and sparking debate, with some outlets suggesting that access to these treatments may exacerbate existing wealth disparities. The effects of these weight-loss drugs are being felt in various parts of the world, including India, and are transforming society in unexpected ways.